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Abstract: Respiratory Syncytial Virus (RSV) causes annual epidemics of respiratory disease particularly affecting 
infants. The associated airway inflammation is characterized by an intense neutrophilia. This neutrophilic inflammation 
appears to be responsible for much of the pathology and symptoms. Previous work from our group had shown that there 
are factors within the airways of infants with RSV bronchiolitis that inhibit neutrophil apoptosis. This study was 
undertaken to determine if RSV can directly affect neutrophil survival. 
Neutrophils were isolated from citrated venous blood (collected from healthy adult volunteers) by discontinuous plasma: 
Percoll gradient centrifugation and, in some experiments, further purified by negative immunomagnetic bead selection. 
The effect of RSV on neutrophil survival was measured by Annexin V-PE /To-Pro-3 staining and by morphological 
changes, using Dif-Quick staining of cytospins. 
Inhibition of neutrophil apoptosis was observed in neutrophils isolated by standard plasma:Percoll gradient when exposed 
to RSV but not in ultra pure neutrophil preparations. Adding monocytes back to ultra purified preparations restored the 
effect. The inhibition of apoptosis was observed with both active and UV inactivated virus. The effect is dependent on a 
soluble factor and appears to be dependent on CD14 receptors on the monocytes. 
Keywords: Respiratory syncytial virus, neutrophils, apoptosis, monocytes. 
INTRODUCTION 
 The human Respiratory Syncytial Virus (hRSV) is 
responsible for annual epidemics of respiratory disease 
affecting all age groups throughout the world. It is a 
particularly important pathogen in infants and young 
children. In the USA alone it is responsible for over 100,000 
infants and young children being admitted to hospital each 
winter with acute bronchiolitis, pneumonia and 
exacerbations of asthma [1]. Its importance as a pathogen in 
the elderly and those with COPD is now well established [2] 
and it has been suggested that RSV is at least as important a 
human pathogen as the influenza virus in all but Influenza 
epidemic years [3]. 
 The inflammation within the airways of infants with RSV 
infections is dominated by neutrophils with these cells 
accounting for more than 80% of cells recovered from both 
the upper and lower airways [4]. Neutrophils are key cells  
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within the innate immune response to invading pathogens. 
Because of the requirement for responding to a range of 
pathogens, neutrophils carry cytotoxic components which 
not only kill any invading organism, but can also cause 
damage to the lungs, either directly or through provocation 
of an inappropriate inflammatory response [5], hence it is 
important that they undergo apoptosis (programmed cell 
death) in a timely manner once activate. Neutrophils in 
culture undergo spontaneous apoptosis within 24 hours [6], 
but many immunological and pathogenic factors have been 
identified which are capable of inhibiting this and prolonging 
the survival of the cells in vitro [7-11]. 
 Previous work has shown that lavage fluid from the 
airways of infants with RSV bronchiolitics and, surprisingly, 
healthy infants contains a soluble factor that is capable of 
inhibiting the apoptosis of neutrophils [12]. No effect on 
PMN apoptosis was noted when lavage samples from health 
adult adults were used. Interestingly a recent study found 
that there are as yet unidentified factors in induced sputum 
from adult asthmatics that are able to inhibit PMN apoptosis 
and that the effect is most marked in the most severely 
affected individuals [13]. An in vitro study suggested that  
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RSV is capable of directly inhibiting the apoptosis of both 
neutrophils and eosinophils directly in vitro [14]. However 
this group used conventionally purified granulocytes that 
frequently contain a small but significant contaminating 
mononuclear cell population. Recent work has shown that 
contaminating monocytes contribute to the anti-apoptotic 
effect of bacterial lipopolysaccharide (LPS) [11, 15], so it is 
vital that neutrophil populations are ultra-purified prior to 
analysis of specific effects on apoptosis [15]. Moreover, the 
purity of the RSV preparation has also been shown to 
influence the results of in vitro studies in that conventionally 
purified virus contains contaminating cytokines and other 
product that can have a significant impact on in vitro 
experiments [16]. 
 The aims of this study were to determine whether RSV 
can directly interact with neutrophils to affect their survival 
and, if not, to explore the potential indirect mechanisms 
through which RSV might influence neutrophil apoptosis. 
Since neutrophils are likely to be of major importance during 
RSV infection, an understanding of the mechanisms driving 
this process may lead to potential therapeutic interventions 
designed to limit the inflammatory response. 
MATERIALS AND METHODS 
Ethics Statement 
 This study involved the use of blood obtained from 
healthy adult volunteers. The study was considered and 
approved by The South Sheffield Research Ethics 
Committee which is associated with the Royal Hallamshire 
Hospital, Sheffield, UK. Informed written consent was 
obtained from all volunteers. 
Isolation of Polymorphonuclear Leucocytes from Human 
Blood Using Discontinuous Plasma: Percoll Gradient 
 Polymorphonuclear Leucocytes (PMNs; neutrophils, 
eosinophils and basophils) were isolated from anti-coagulated 
freshly drawn venous blood from healthy adult volunteers. 
 PMNs were separated from the peripheral blood 
mononuclear cells (PBMCs) by discontinuous plasma: 
Percoll gradient centrifugation [17]. 
Analysis of Purity of Plasma: Percoll Purified 
Neutrophils 
 Cells were stained with FITC conjugated antibodies to 
CD3, CD19 and CD56 (all Serotec) or a PE conjugated anti-
CD66 antibody (BDBiosciences) and analysed by flow 
cytometry using a FACSCalibur flow cytometer (Beckton 
Dickinson). 
 Using flow cytometry analysis of cell surface markers, a 
typical plasma: Percoll purified neutrophil preparations 
contained 87% (± 6.5%, n=6) CD66 positive granulocytes, 
3% (± 2%, n=4) CD3 positive T cells, 1% (± 0.5%, n=5) 
CD19 positive B cells, 0.8% (± 0.6%, n=5) CD36 positive 
monocytes and 1% (n=2) CD56 positive Natural Killer Cells, 
with any remaining being red blood cells or CD3 negative T 
cells. 
 Assessment of the nature of the granulocytes was done 
by assessment of cytospin slides. Basophils were never 
observed in the preparations and eosinophils made up less 
than 10% of the cell population. 
Ultra Purification of PMNs. 
 Ultra-purification of PMNs was performed using 
negative immunomagnetic selection [11]. Briefly, the 
resultant PMN layer from the plasma: Percoll gradient was 
incubated with an antibody cocktail containing antibodies to 
CD2, CD3, CD19, CD36, CD56 and Glycophorin and 
magnetic colloid (both StemCell Technologies) and run 
through a StemSep
TM
 immunomagnetic column (StemCell 
Technologies). 
 All preparations were 99.2 (± 0.2%, n=5) CD66 positive 
granulocytes. The flow cytomery plots of these cells showed 
very few events outside the granulocyte gates (Fig. 1) and 
PBMCs were not observed on cytocentrifuge slides. PMNs 
Basophils were never observed in the preparations and 
eosinophils made up less than 10% of the population (by 
cytocentrifuge slide counts). 
Ultra-Purification of Monocytes from the PBMC Layer 
 A cocktail containing antibodies to CD2, CD3, CD16, 
CD19, CD20, CD56, CD66b, CD123 and Glycophorin A 
along with magnetic colloid (both StemCell Technologies) 
was added and the cells were purified using the StemSep
TM
 
system (StemCell Technologies). 
Add Back Experiments 
 Following cell purifications, ultra purified PMNs and 
monocytes were mixed together in described ratios. The cells 
were mixed together and aliquoted for infection to ensure 
even distribution of cells within an experiment. 
Depletion of Individual PBMC Populations 
 Individual PBMC populations were depleted from the 
plasma: Percoll purified population by anti-Fluorescein 
Isothiocyanate (FITC) positive immunomagnetic selection. 
An anti-CD3 antibody was used to deplete T cell, an anti-
CD19 antibody to deplete B cells, an anti-CD56 antibody to 
deplete Natural Killer Cells and both anti-CD14 and anti-
CD36 antibodies for monocytes. 
 Cells were depleted using the anti-FITC isolation kit 
according to the manufacturer’s instructions and the 
EasySepp
TM
 isolation system (all StemCell technologies). 
Negative populations were retained and used in experiments. 
Maintenance of Cells in Culture 
 All cell populations were maintained in RPMI medium 
(Sigma) supplemented with 10% Foetal Bovine Serum (FBS; 
Invitrogen) and 1% Penicillin and Streptomycin (Sigma). 
Identification of Neutrophils on Flow Cytometry Plots 
 For analysis, neutrophils are identified on flow cytometry 
Forward Scatter Side Scatter plots. Representative dot plots 
of plasma: Percoll purified and ultra-purified populations are 
shown in Fig. (1). Neutrophils were gated upon, as 
demonstrated in Fig. (1), for the study of apoptosis in this 
population exclusively. 
Analysis of Apoptosis 
 Neutrophil apoptosis was assessed by both Annexin V/ 
TO-PRO 3
TM
 staining and morphological staining of 
cytocentrifuge slides. 
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Fig. (2). Representative plot obtained from an AnnexinV/TO-
PRO 3
TM
 stain on mock infected plasma:Percoll purified 
neutrophils after 24 hours of culture. Plot shows all 3 possible 
stains: double negative cells are viable, Annexin V positive only 
cells are apoptotic and double positive cells are late 
apoptotic/necrotic. 
 Following maintenance in culture, cells were harvested 
and stained with Annexin V conjugated to Phycoerythrin 
(PE) according to the manufacturer’s instructions (BD 
BioSciences). Just prior to analysis, TO-PRO 3
TM
 (Molecular 
Probes) was added at a final dilution of 1:10,000 into the 
sample. Cells were analysed using a FACSCalibur flow 
cytometer (Beckton Dickinson). Cells were judged to be 
viable if double negative, early apoptotic if positive for 
Annexin V alone and necrotic or late apoptotic if double 
positive (as shown in Fig. 2). In these experiments 
significant TO-PRO 3
TM
 positivity was only observed at late 
time points, so was assumed to be late apoptosis. 
 Concurrently, cytocentrifuge preparations were made 
(Cytospin 3; Shandon), fixed in methanol (BDH) and stained 
with DiffQuick stains (Dade Behring). Slides were examined 
using oil immersion microscopy and apoptosis was 
confirmed by characteristic nuclear morphology. The 
DiffQuick stain stains the nucleus purple. Live neutrophils 
have a characteristic multi-lobed nucleus with light staining, 
whilst apoptotic neutrophils have a small, round nucleus 
with intense purple staining. 
RSV Production 
 The A2 strain of RSV was propagated in HeLa cells by 
infection of 90% confluent cell cultures with A2-RSV and 
subsequent culture for 2 days. Contaminating cytokines were 
removed from the A2-RSV containing HeLa cell media 
using a Vivaspin 20 1,000,000 Dalton pore size (Sartorius, 
Goettingen, Germany) centrifugation filters as described 
previously [16]. An immunohistochemical plaque assay for 
RSV was performed by serial dilution onto HeLa cells and 
subsequent staining for RSV as described previously [16]. 
Inactivation of the Virus by Ultra-Violet (UV) 
Irradiation 
 Virus was made replication deficient by placing it in a 
Stratalinker UV Crosslinker (Stratagene, USA) for 10 
minutes at full power (~ 4000 μwatts/cm2). 
 Non-infectivity of the virus was confirmed by plaque 
assay. 
Testing of Viral Stocks for Lipopolysaccharide 
Contamination 
 Virus stocks were tested for LPS contamination using the 
E-TOXATE (Sigma) method according to the 
manufacturer’s instructions. 
 No significant LPS contamination was found in any viral 
stock used in this study. 
Infection of Neutrophil Cultures with RSV 
 Freshly isolated cell populations were infected with RSV 
at a multiplicity of infection (m.o.i.) of 0.5, 1, 2 or 10. The 
appropriate volume of virus was added immediately after 
cell isolation to 0.25x10
6
 cells in 100ul total volume and 
cells were cultured under standard neutrophil culture 
conditions as described above. 
Inhibition of CD14 Signalling 
 A known CD14 blocking antibody (clone number MEM-
18) was used, along with an isotype control (both from 
Abcam), at a concentration of 10μg/ml. 
 
Fig. (1). Representative dot plots of plasma: Percoll (A) and ultra-purified (B) neutrophil populations. Discrete cell populations can be 
identified, as shown in A: M = monocytes; L = lymphocytes; N = neutrophils; E = eosinophils; D = red blood cells and any cellular debris. 
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Collection and Heat-Inactivation of Monocyte 
Conditioned Media 
 Purified monocytes were challenged with RSV at an 
m.o.i. of 2 for 12 hours; the media was collected and added 
to ultra-purified neutrophils at a concentration of 1:1 into the 
cells. Additionally, the media was heat treated by boiling at 
90
o
C for 15 minutes. 
Cytokine Bead Array 
 Plasma:Percoll pure and ultra-pure neutrophils were 
incubated with A2-RSV at m.o.i.’s of 2 or 10 for 12 hours. 
The supernatant was collected, snap-frozen and stored at -
80
o
c until 4 sets of samples, from independent donors, were 
collected. All samples were run at the same time and levels 
of Interferon-, Tumour Necrosis Factor-, Interleukin (IL)-
1, IL-6, IL-9, IL-10, IL-12p70, Granulocyte Colony 
Stimulating Factor, Granulocyte-Macrophage Colony 
Stimulating Factor, Macrophage Inflammatory Protein 
(MIP)-1 and MIP-1 were measured using Cytokine Bead 
Array kits and a FACSArray Flow Cytometer (Beckton 
Dickinson). The upper detection limit for each 
cytokine/chemokine is 5000pg/ml, the precise lower 
detection limit varied between cytokines depending on the 
standard curve, but was always 10-20pg/ml. 
Data Analysis and Statistics 
 Data are presented as mean + SEM. 
 Percentage of cells in apoptosis is continuous numerical 
data that can be considered normally distributed for 
statistical purposes. To assess the effect of purification on 
RSV mediated neutrophil apoptosis, where cells are matched 
according to the donor; data were assessed by two-way 
ANOVA. 
 To compare individual treatments or cell populations to 
each other within the entire data set, the Bonferroni multiple 
comparison post-test was used. 
 All statistical analyses were performed using the Minitab 
statistical analysis software. 
 Differences were considered to be statistically significant 
where p<0.05. 
RESULTS 
RSV Inhibits the Apoptosis of Peripheral Blood 
Neutrophils, But Only in the Presence of Contaminating 
Monocytes 
 RSV is capable of inhibiting the apoptosis of peripheral 
blood neutrophils in plasma: Percoll purified cell 
populations, as shown in Fig. (3). RSV statistically 
significantly inhibits the apoptosis of plasma: Percoll 
purified neutrophils at m.o.i.’s of 2 and 10 at 12 and 24 
hours post-infection. 
 When contaminating PBMCs are removed from the cells by 
ultra-purification, there is a statistically significant attenuation of 
 
 
Fig. (3). Effect of RSV on neutrophil apoptosis in plasma: Percoll purified cells at 4 (A), 8 (B), 12 (C) and 24 (D) hours post infection. 
Data are presented as mean values, with error bars indicating the standard error, of 5 independent experiments on independent donors. Levels 
of significance are shown as *, p<0.05; **, p<0.01. 
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the anti-apoptotic effect of the virus, as shown in Fig. (4). The 4 
hour time point is not shown in Fig. (4), as levels of apoptosis 
are very low at this time point (Fig. 3A). Cells exposed to virus 
titres at both 12 and 24 hours post-infection show a statistically 
significant increase in apoptosis upon removal of the PBMCs 
(for example, m.o.i. of 2 at 12 hours: plasma: Percoll vs ultra 
pure = 16.17% ± 4.13 SEM vs 40.31 ± 2.89 SEM; two-way 
ANOVA + BONFERRONI: t = 4.79, p<0.001). Removal of 
PBMCs had no statistically significant effect on the constitutive 
apoptosis of mock infected neutrophils. 
 Typically, ultra-purification of the plasma: Percoll 
population yielded 50-75% granulocyte return, which is 
lower than the CD66 stain implies, thus to confirm that the 
column purification had no effect on the biology of the 
neutrophils themselves, or was selectively removing a more 
RSV responsive neutrophil population, 5% donor matched 
mixed PBMCs were added back to ultra-purified populations 
and then infected with RSV. The RSV mediated inhibition of 
neutrophil apoptosis was restored in these populations (data 
not shown). 
 When CD14 (a monocye marker) depletion experiments 
were performed, the anti-apoptotic effect of the RSV was 
statistically significantly attenuated, as shown in Fig. (5). For 
all m.o.i.’s of the virus, there is a statistically significant 
effect of removing the CD14 positive population on 
apoptosis of neutrophils (for example, at m.o.i. of 2: plasma: 
Percoll pure vs CD14 depleted = 9.15% ± 3.08 SEM vs 21.37 
± 0.98 SEM; p<0.05). Removal of the CD14 positive 
population has no statistically significant effect on 
constitutive apoptosis (mock infected controls). Furthermore, 
depletion of CD3 (T Cells), CD19 (B Cells) and CD56 
(Natural Killer Cells) showed no effect on the RSV mediated 
inhibition of neutrophil apoptosis (Table 1). 
 When ultra-purified monocytes are added back to ultra-
purified neutrophils there is a restoration of the RSV 
mediated anti-apoptotic effect, as shown in Fig. (6). Though 
addition of 5% monocytes statistically significantly inhibits 
constitutive neutrophil apoptosis, there is a much larger and 
more statistically significant difference between the 
populations in the presence of all RSV doses (for example, at 
the m.o.i. of 2: ultra pure vs 5% add-back = 51.53% ± 7.37 
SEM vs 33.58 ± 7.59 SEM; two-way ANOVA + 
BONFERRONI: t = 5.08, p<0.001). 1% monocyte add-back 
is not sufficient to restore the anti-apoptotic effect, though, at 
the m.o.i. of 2, in particular, there is evidence of a dose 
dependent effect of the monocytes (51.53% vs 44.04% vs 
33.58% for mock, 1% and 5% respectively). 
CD14 is Required for the Anti-Apoptotic Effect 
 When a CD14 blocking antibody was added to plasma: 
Percoll purified cell cultures, the anti-apoptotic effect of 
RSV was statistically significantly attenuated as shown in 
Fig. (7). 
The Virus Does Not have to be Fully Infectious to have its 
Anti-Apoptotic Effect  
 When UV-inactivated A2-RSV is added to plasma: 
Percoll purified neutrophils with concurrent untreated 
controls (both at an m.o.i. of 2), there is no statistically 
significant effect on the RSV mediated inhibition of 
neutrophil apoptosis, as shown in Fig. (8). 
 
Fig. (4). Effect of RSV on neutrophil apoptosis in plasma: 
Percoll purified and ultra purified cells at 8 (A), 12 (B) and 24 
(C) hours post infection. Data are presented as mean values, with 
error bars indicating the standard error, of 5 independent 
experiments on independent donors. Levels of significance are 
shown as *, p<0.05; **, p<0.01; ***, p<0.001; ns = not statistically 
significant. 
Monocytes Challenged with RSV Produce a Heat Labile, 
Soluble Factor which Blocks Neutrophil Apoptosis 
 The media from RSV treated monocytes statistically 
significantly inhibited neutrophil apoptosis as compared to 
untreated monocyte media (p<0.01) and this effect can be 
removed by heat treatment (p<0.01), as shown in Fig. (9). 
Cytokine and Chemokine Analysis 
 In an effort to determine if there was a particular 
cytokine or chemokine responsible for the anti-apoptotic 
effect, a cytokine bead array was performed on samples from  
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Fig. (5). Effect of RSV on neutrophil apoptosis in a CD14 
depleted cell population at 12 hours post-infection. Data are 
presented as mean values, with error bars indicating the standard 
error, of 3 independent experiments on independent donors. Data 
was analysed by two way ANOVA and the Bonferroni post-test. 
Levels of significance are shown as **, p<0.01; *, p<0.05. ns = not 
statistically significant. 
 
Fig. (6). Effect of RSV on neutrophil apoptosis in ultra purified 
neutrophils with 1% and 5% monocyte add-backs at 12 hour 
time point. Data are presented as mean values, with error bars 
indicating the standard error, of 3 independent experiments on 
independent donors. Data was analysed by two way ANOVA and 
the Bonferroni post-test. Levels of significance are shown as *, 
p<0.05; **, p<0.01; ***, p<0.001. 
 
Fig. (7). Effect of a CD14 blocking antibody, or the relevant 
isotype control on RSV inhibition of neutrophil apoptosis at the 
stated m.o.i.’s at 12 hours post-infection. Data are presented as 
mean values, with error bars indicating the standard error, of 3 
independent experiments on independent donors. Data was 
analysed by two way ANOVA and the Bonferroni post-test. Levels 
of significance are shown as **, p<0.01; *, p<0.05. 
both plasma: Percoll and ultra purified cells challenged with 
RSV at an m.o.i. of 2 or 10, the results of which are shown in 
Tables 2 and 3 respectively. The cells were treated the same 
as in all other experiments, therefore the cytokine/chemokine 
values shown were produced from 0.25x10
6
 cells treated 
with RSV. A 12 hour time point was chosen as a time point, 
as this point shows significant inhibition of neutrophil 
apoptosis (Fig. 3) and a significant difference between 
plasma:Percoll purified and ultra purified cell populations 
(Fig. 4). 
 These data show that a range of pro-inflammatory 
cytokines and chemokines are upregulated in plasma:Percoll 
purified cells in response to RSV in a dose dependent 
manner. However, in ultra-purified cell populations, only 
MIP-1 and MIP-1 are significantly upregulated in a dose 
dependent manner. 
 Following on from these results, the effects of 
recombinant MIP-1 and MIP-1 (R&D Technologies) were 
used to assess if either of these chemokines are capable if 
inhibiting neutrophil apoptosis. Neither had any effect at any 
concentration tested (data not shown). 
DISCUSSION 
 The results from this study would indicate that the 
Respiratory Syncytial Virus does not directly influence the 
survival of neutrophils. However, one or more soluble 
mediators released by monocytes exposed to RSV do have a 
statistically significant impact on neutrophil survival. These 
Table 1. Representative Data of the Effect of Depletion of CD3 Positive, CD19 Positive and CD56 Positive Cells from Plasma: 
Percoll Purified Neutrophil Populations. Cells were Infected with RSV at an m.o.i. of 2 and Apoptosis was Assessed at 12 
Hours Post-Infection. Experiments were Performed at Least Twice on Cells from Different Donors 
 
Depletion  
Performed. 
Donor Matched Plasma: Percoll Purified Neutrophils  
(% of Apoptotic Cells) 
Donor Matched Ultra Purified Neutrophils  
(% of Apoptotic Cells) 
Depleted Cell Population  
(% of Apoptotic Cells) 
CD3 6.34% 30.90% 9.2% 
CD19 16.37% 31.58% 18.06% 
CD56 15.33% 26.67% 6.00% 
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results are consistent with our previous results which 
indicated that RSV does not directly activate neutrophils in 
vitro [16]. The results contrast with a number of other 
published studies which have suggested a number of 
interactions between virus and neutrophils [12, 14, 16, 18-
21], but is of note that all of these studies have potential 
problems regarding the purity of virus [16] and/or 
neutrophils [15]. 
The importance of ultra-purifying neutrophil populations in 
order to assess the direct effects of factors upon neutrophil 
biology has been demonstrated in the context of the effects 
of LPS on neutrophil survival [11]. Ultra-purification of 
neutrophils has no significant effect on the fundamental 
biology of the neutrophils, with cells still able to respond to 
LPS and no difference in TLR expression patterns [11],  
 
though PBMCs do inhibit neutrophil apoptosis by their 
presence in the absence of other stimuli [15]. It has also been 
shown that LPS has a significantly greater effect on 
inhibiting neutrophil apoptosis in the presence of the small 
numbers of contaminating monocytes present in standard 
purified neutrophil populations [11], indicating the 
importance of using highly purified neutrophil populations to 
study specific interactions with pathogenic stimuli [15]. 
 In the specific case of the effect of RSV on neutrophil 
apoptosis, one study appeared to indicate that RSV directly 
inhibits the apoptosis of neutrophils [11] but they use a PMN 
population similar to that purified by plasma: Percoll 
gradient in this study and it is now clear from the results 
from the current study that the purity of the PMN population 
is of vital importance to the study of RSV interactions with 
neutrophils when undertaking in vitro studies. 
Table 2. Cytokine and Chemokine Levels, Measured in pg/ml, in Plasma: Percoll Purified Cell Population in Presence or Absence 
of A2-RSV 
 
 Mock A2-RSV (m.o.i. 2) A2-RSV (m.o.i. 10) 
IFN- 14.16 BDL BDL 
TNF- 2.83 66.55±19.86 304.63±106.92 
IL-1 5.04 60.85±19.62 113.57±23.56 
IL-6 BDL 370.78±211.30 1456.74±714.64 
IL-9 27.09 13.66±13.66 17.18±10.55 
IL-10 2.71 6.76±2.96 15.02±4.84 
IL-12p70 BDL 5.01±5.01 BDL 
G-CSF BDL 18.76±6.39 53.38±22.71 
GM-CSF 4.03 3.44±3.44 2.61±2.61 
MIP-1 2.69 765.37±199.18 3823.72±855.41 
MIP-1 70.00 ADL ADL 
Data is mean values +/- standard error of 4 independent experiments. Mock infected controls are mean values of 2 independent experiments. BDL = below detection limit; ADL = 
above detection limit. 
 
Table 3. Cytokine and Chemokine Levels, Measured in pg/ml, in the Ultra Purified Cell Population in Presence or Absence of A2-
RSV 
 
 Mock A2-RSV (m.o.i. 2) A2-RSV (m.o.i. 10) 
IFN- BDL BDL BDL 
TNF- BDL 2.46±1.50 1.53±1.53 
IL-1 BDL 2.73±1.63 2.33±2.33 
IL-6 BDL 7.91±2.29 16.40±5.05 
IL-9 24.43 7.15±7.15 3.99±3.99 
IL-10 BDL 2.65±1.53 BDL 
IL-12p70 BDL BDL 2.78±2.78 
G-CSF BDL BDL 4.71±4.71 
GM-CSF BDL BDL 2.67±2.67 
MIP-1 BDL 25.21±4.47 114.69±46.45 
MIP-1 BDL 816.00±147.60 3307.50±865.19 
Data is shown as mean values +/- standard error of 4 independent experiments. Mock infected controls are mean values of 2 independent experiments. BDL = below detection limit. 
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Fig. (8). Effect of a UV inactivation on the anti-apoptotic effect 
of RSV at an m.o.i. of 2 at 12 (A) and 24 (B) hours post 
infection. Data are presented as mean values, with error bars 
indicating the standard error, of 3 independent experiments on 
independent donors. Data was analysed by one way ANOVA and 
the Bonferroni post-test. Levels of significance are shown as **, 
p<0.01; *, p<0.05. 
 The only samples in which any effect of RSV was noted 
on ultra purified PMNs was when an m.o.i. of 10 was used 
(an unrealistic dose in an in vivo situation) and even this may 
be caused by a very small number of highly stimulated 
monocytes surviving the purification procedure. 
 We have shown that monocytes are the PBMC 
responsible by both removal (Fig. 5) and add-back 
experiments (Fig. 6). Greater than 1% monocyte 
contamination is required for a statistically significant effect 
to be observed in vitro (Fig. 6). Interestingly when 1% 
monocytes are added back, the degree of inhibition of 
neutrophil apoptosis is not as great as observed in the 
plasma: Percoll purified and did not reach statistical 
significance, even though this is the maximum level of 
monocyte contamination observed in these cultures. This 
may be because the other cells in the plasma: Percoll 
population are interacting with the monocytes and PMNs. 
Removal of specific individual populations (CD3, CD19 and 
CD56 depletions) may not have a statistically significant 
effect on its own due to redundancy within the system should 
monocytes release factor(s) causing pro-inflammatory 
cytokine release from a number of leucocytes. In this model, 
removal of just T cells, for example, will have a negligible 
effect, but removal of the monocytes will block the whole 
network of effects while addition of just monocytes to ultra 
pure populations will limit interactions to RSV, monocyte 
and neutrophil without the potential for networking with 
other cell populations. 
 
Fig. (9). Effect of both untreated and heat treated media from 
RSV and mock infected monocytes (12 hours post-infection) on 
neutrophil apoptosis at 12 hours post treatment. Data are 
presented as mean values, with error bars indicating the standard 
error, of experiments using 6 independent monocyte donors. Data 
was analysed by one way ANOVA and the Bonferroni post-test. 
Levels of significance are shown as **, p<0.01. 
 Interestingly UV inactivation of RSV did not diminish 
the inhibition of apoptosis (Fig. 8) indicating that viral 
replication is not necessary. The ability of non-viable RSV to 
inhibit PMN apoptosis has previously been observed in a 
study in which RSV was inactivated by heat treatment [14]. 
These data suggest that a viral structural protein (or the viral 
RNA) is responsible for the effect. A knock out mutant of 
the membrane Glycoprotein was utilised but showed no 
attenuation in this model (data not shown). 
 Blocking CD14 mediated signalling in these cultures 
statistically significantly attenuated the anti-apoptotic effect 
of RSV (Fig. 7), implying a role for Toll Like Receptors 
(TLRs). Both TLR4 [22], TLR3 [23] and TLR2 complexes 
[24-27] are known to complex with CD14. A number of 
studies have attempted to determine whether there is a direct 
interaction between RSV and TLR4. The evidence is 
conflicting with some papers suggesting a role for this 
molecule in RSV pathogenesis [28-30] and others suggesting 
that there is no direct interaction [14, 31]. Kurt-Jones et al. 
showed that TLR4/CD14 complexes and interactions with 
the RSV F protein are vitally important for RSV clearance 
[30], though it has since been suggested that this observation 
is a result of the mouse strain utilised in these experiments, 
which also has a knock-out in the Interleukin 12 receptor 
[31]. In the context of RNA virus infection, the interaction 
between TLR3 and CD14 may be important [23]. RSV has 
been shown to cause upregulation of TLR3 in infected 
airways [32] and interactions between RSV and TLR3 cause 
pro-inflammatory cytokine release from epithelial cells [33], 
though no studies have investigated this effect in monocytes 
or other immune cells. A recent study has suggested that the 
TLR2/TLR6 heterodimeric complex may be involved in 
RSV pathogenesis. RSV infection of TL2/TLR6 knockout 
mice was associated with decreased cytokine production, 
neutrophil recruitment and dendritic cell activation [34]. The 
exact role of CD14 signalling in monocytes in the 
pathogenesis of the disease and indeed in neutrophil survival 
remains to be determined. 
 Neutrophils themselves express a low level of CD14 on 
the cell surface [35], so it is possible that the CD14 blocking  
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antibody is also blocking CD14 on the neutrophils and 
inhibiting the RSV mediated inhibition of apoptosis. The 
antibody cocktail used to ultra-purify the neutrophils does 
not contain a CD14 antibody and it has been shown that even 
when such an antibody is used to purify the cells, there is no 
significant effect on neutrophils [36]. Thus, the CD14 
mediated signalling pathway will not be blocked in the ultra-
purified cultures and RSV still does not inhibit apoptosis in 
these cultures; however, we cannot exclude that possibility 
that the high dose RSV inhibits neutrophil apoptosis via 
CD14 on the neutrophils. 
 We were able to demonstrate that monocytes produce a 
heat labile factor in response to RSV challenge, which is 
capable of inhibiting neutrophil apoptosis (Fig. 9). In order 
to assess whether this factor was a cytokine/chemokine, we 
assessed production of a number of these by Cytokine Bead 
Array in the plasma: Percoll and ultra-purified cell 
population. A number of cytokines and chemokines are up-
regulated in plasma: Percoll purified samples (Table 2). 
However in the ultra purified samples (Table 3) most of 
these cytokines were not present in statistically significant 
quantities. Though levels of MIP-1 and MIP-1  were 
reduced 10 fold in the ultra-purified preparations they were 
still present in statistically significant quantities supporting 
the suggestion that an extremely small number of residual 
monocytes are probably still present. 
 We were unable to positively identify the factor 
responsible for the anti-apoptotic effect of RSV and finding 
such a factor will be a significant undertaking, as many host 
factors are known to inhibit neutrophil apoptosis [7-9, 12]. It 
remains possible that no single factor is responsible and 
there is a synergistic relationship between a number of 
factors, indeed Tables 2 and 3 show up-regulation of a 
number of known anti-apoptotic cytokines (IL-1, IL-6 and 
TNF-). Previous attempts to identify the soluble heat labile 
factor(s) in airways lining fluid from infants with RSV 
infection that in airways lining fluid using inhibitors against 
the most likely candidates also failed to identify a single 
mediator [12] supporting the suggestion that a number of 
factors are involved. A recent publication using induced 
sputum samples from asthmatic subjects observed a similar 
effect on PMN survival but they too were unable to identify 
the factor(s) responsible [13]. The similarity in results 
reported when using samples from asthmatics and from 
infants with an acute viral respiratory tract infection would 
suggest that the inhibition of PMN apoptosis is a not specific 
to neither respiratory viral infections nor asthma. 
 The importance of monocytes in mediating the inhibition 
of neutrophil apoptosis is perhaps not surprising given their 
importance in generating cytokines and other factors in 
response to RSV [37-44]. The significance of the inhibition 
of neutrophil apoptosis in the pathogenesis of the disease is 
unclear. There does seem to be little doubt that the intense 
neutrophilia observed in the airways of infants with acute 
bronchiolitis contribute significantly to symptoms and 
disease severity through the release of products such as 
human neutrophil elastase and myeloperoxidase which 
induce mucus secretion, airways oedema and cough. Indeed 
this inflammatory response with considerable amounts of 
airways secretions in both the upper and lower airways 
together with coughing and sneezing would appear to be 
ideally suited to transmission of the virus. To date there is no 
evidence that the intense neutrophil response observed in 
primary infection in infants contributes to eliminating or 
indeed limiting RSV infection. However, it remains possible 
that neutrophils do have a role in vivo in eliminating virus 
either in the presence of antibody attached to the virus or 
following neutrophil activation 
 These experiments indicate that the inhibition of 
neutrophil apoptosis by RSV observed in vitro and in vivo is 
secondary to activation of monocytes, which produce a heat 
labile soluble factor(s) and that this process is initiated in 
response to one or more structural proteins or viral RNA. 
This study, and our previous study indicating that RSV does 
not directly activate neutrophils [16], would suggest that the 
Respiratory Syncytial Virus does not interact directly with 
neutrophils. 
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